Analytic evaluation of the β-human chorionic gonadotropin assay on the Abbott IMx and Elecsys2010 for its use in doping control

Clinical Biochemistry

Volumn 40, Issue 16-17, 2007, Pages 1259-1265

  Shahzad, Khurram ^a   Kim, Dong Hyun ^a   Kang, Min Jung ^a  

^a Korea Institute of Science and Technology   (South Korea)

Author keywords

hCG; Confirmation method; Doping control; Elecsys2010; IMx; Method evaluation; Non isotopic immunoassay

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT;

ADULT; ARTICLE; ATHLETE; CLINICAL EVALUATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DOPING; ELECSYS; FEMALE; GONADOTROPIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; IMMUNOASSAY; IMX; LINEAR REGRESSION ANALYSIS; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN STABILITY; ROOM TEMPERATURE; RUNNING; URINALYSIS;

CALIBRATION; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; CLINICAL CHEMISTRY TESTS; DOPING IN SPORTS; HUMANS; REFERENCE STANDARDS; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS;

EID: 35348904056     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2007.06.015     Document Type: Article

References (32)

1. Hussa R.O. The Clinical Marker hCG (1987), Praeger, New York 1-9
2. Pierce J.G., and Parsons T.F. Glycoprotein hormones: structure and function. Annu. Rev. Biochem. 50 (1981) 465-495
3. Kicman A.T., Brooks R.V., and Cowan D.A. Human chorionic gonadotropin and sports. Br. J. Sports Med. 25 (1991) 73-80
4. Kicman A.T., and Cowan D.A. Peptide hormones and sport: misuse and detection. Br. Med. Bull. 48 (1992) 496-517
5. Cowan D.A., Kicman A.T., Walker C.J., and Wheeler M.J. Effects of administration of human chorionic gonadotropin on criteria used to assess testosterone administration in athletes. J. Endocrinol. 131 (1991) 147-154
6. De Boer D., De Jong E.G., Van Rossum J.M., and Maes R.A.A. Doping control of testosterone and human chorionic gonadotropin: a case study. Int. J. Sports Med. 12 (1991) 46-51
7. Rommerts F.F.G., and Cooke B.A. The mechanism of action of leutinizing hormone II. Transducing system and biological effects. In: Cooke B.A., King R.J.B., and van der Molen H.J. (Eds). Hormones and Their Actions. Part II (1988), Elsevier, Amsterdam 163-180
8. World Anti-doping Agency; http://www.wada-ama.org.
9. Cowan D.A., and Kicman A.T. Doping in sport: misuse, analytical tests and legal aspects. Clin. Chem. 43 (1997) 1110-1113
10. Stenman U.-H., Unkila-Kallio L., Korhonen J., and Alfthan H. Immunoprocedures for detecting human chorionic gonadotropin: clinical aspects and doping control. Clin. Chem. 43 (1997) 1293-1298
11. Delbeke F.T., Van Eenoo P., and De Backer P. Detection of human chorionic gonadotropin misuse in sports. Int. J. Sports Med. 19 (1998) 287-290
12. Sotorrio P., Quiros A., and Izquierdo J.M. New immunoelectrochemiluminometric assay to measure serum thyrotropin. Clin. Chem. 43 (1997) 2428-2430
13. Munro C.J., Laughlin L.S., Illera J.C., Dieter J., Hendrickx A.G., and Lasley B.L. ELISA for the measurement of serum and urinary chorionic gonadotropin concentrations in the laboratory macaque. Am. J. Primatol. 41 (1997) 307-322
14. Cole L.A. Immunoassay of human chorionic gonadotropin, its free subunits, and metabolites. Clin. Chem. 43 (1997) 2233-2243
15. Carayannopoulos M.O., David G., Grenache D.G., and Gronowski A.M. Total β-human chorionic gonadotropin measured in urine by an automated method. Clin. Chem. 10 (2002) 1796-1797
16. Forest J.C., Masse J., and Lane A. Evaluation of the analytical performance of the Boehringer Mannheim Elecsys 2010 Immunoanalyzer. Clin. Biochem. 31 (1998) 81-88
17. Blackburn G.F., Shah H.P., Kenten J.H., et al. Electrochemiluminescence detection for development of immunoassays and DNA probe assays for clinical diagnostics. Clin. Chem. 37 (1991) 1534-1539
18. Faulkner L.R., and Bard A.J. Techniques of electrogenerated chemiluminescence. In: Bard A.J. (Ed). Electroanalytical Chemistry (1977), Marcel Dekker, New York 1-95
19. Leland J.K., and Powell M.J. Electrogenerated chemiluminescence: an oxidative-reduction type ECL reaction sequence using tripropyl amine. J. Electrochem. Soc. 137 (1990) 3127-3131
20. World Anti-doping Agency. WADA standards and harmonization: guidelines for urine samples collection, June 2004. Version 4. p. 1-22 (http://www.wada-ama.org/rtecontent/urine_testing_guideline.Pdf).
21. Lasky F.D., Powers D.M., Hassemer D.J., and Wiebe D.A. Quality of fluids used in external quality control programs affects the reliable assessment of accuracy of routine methods, as documented by cholesterol. In: Kawai T., Ohba Y., Kanno T., et al. (Eds). Proceedings of the 7th International Symposium on Quality Control. Tokyo: Excerpt Medica (1992) 199-208
22. Cole L.A., and Kardana A. Discordant results in human chorionic gonadotropin assays. Clin. Chem. 38 (1992) 263-270
23. Kiburis J. The need for standardization of the hCG assays in doping control. In: Belloti P., Benzi G., and Ljungqvist A. (Eds). Official Proceedings of the Second World Symposium on Doping in Sport 1989 (1990), International Amateur Athletic Federation, London 31-36
24. Lasky F.D. Achieving accuracy for routine clinical chemistry methods by using patient specimen correlations to assign values: a means of managing matrix effects. Arch. Pathol. Lab. Med. 117 (1993) 412-419
25. Halldorsdottir A.M., Carayannopoulos M.O., Scrivner M., and Gronowski A.M. Method evaluation of total β-human chorionic gonadotropin using urine and the ADVIA Centaur. Clin. Chem. 49 (2003) 1421-1422
26. Ikomi A., Matthews M., Kuan A.M., and Henson G. The effect of physiological urine dilution on pregnancy test results in complicated early pregnancies. Br. J. Obstet. Gynaecol. 105 (1998) 462-465
27. Franek M. Structural aspects of steroid-antibody specificity. J. Steroid Biochem. 28 (1987) 95-108
28. O'Connor T., and Gosling J.P. The dependence of RIAs detection limits on antibody affinity. J. Immunol. Methods 208 (1997) 181-189
29. Alison M.J., and Honour W.J. Unusual results from immunoassays and the role of the clinical endocrinologist. Clin Endocrinol.?? 64 (2006) 234-244
30. Taieb J., Olivennes F., Birr A.S., et al. Comparison of day 3 FSH serum values as determined by six different immunoassays. Hum. Reprod. 17 (2002) 926-928
31. Witherspoon L.R., Shuler S.E., Joseph G.F., Baird E.F., Neely H.R., and Sonnemaker R.E. Immunoassays for quantifying choriogonadotropin compared for assay performance and clinical application. Clin. Chem. 38 (1992) 887-897
32. Birken S., Berger P., Bidart J.M., et al. Preparation and characterization of new WHO reference reagents for human chorionic gonadotropin and metabolites. Clin. Chem. 49 (2003) 144-154